Molecular Genetics of Follicular-Derived Thyroid Cancer

被引:35
|
作者
Macerola, Elisabetta [1 ]
Poma, Anello Marcello [1 ]
Vignali, Paola [1 ]
Basolo, Alessio [2 ]
Ugolini, Clara [1 ]
Torregrossa, Liborio [1 ]
Santini, Ferruccio [2 ]
Basolo, Fulvio [1 ]
机构
[1] Univ Pisa, Dept Surg Med Mol Pathol & Crit Area, Via Savi 10, I-56126 Pisa, Italy
[2] Univ Pisa, Dept Clin & Expt Med, Via Savi 10, I-56126 Pisa, Italy
关键词
molecular genetics; molecular pathology; thyroid cancer; papillary thyroid cancer; TERT PROMOTER MUTATIONS; NUCLEAR FEATURES NIFTP; BRAF; TUMORS; LAROTRECTINIB; PATHOGENESIS; ASSOCIATION; MANAGEMENT; INHIBITORS; LANDSCAPE;
D O I
10.3390/cancers13051139
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Thyroid tumors that derive from follicular cells are not a homogeneous entity, showing variable morphological appearance and different degrees of differentiation. Molecular markers are useful for both diagnostic purposes and prognostic stratification of patients. In presurgical setting, molecular testing of indeterminate thyroid nodules on aspirates provides useful diagnostic information; the molecular analysis on tumor tissues can also reveal the presence of genetic alterations related to patients' prognosis. In recent years, the molecular characterization of these tumors has acquired even more importance thanks to the introduction of targeted drugs. This review summarizes the current literature on the molecular landscape of follicular-derived thyroid tumors. Thyroid cancer is the most common type of endocrine-related malignancy, whose incidence rates have increased dramatically in the last few decades. Neoplasms of follicular origin generally have excellent prognosis, with the exception of less differentiated tumors. Follicular-derived thyroid cancer can manifest as a variety of morphologically distinct entities, characterized by various degrees of differentiation and invasiveness. Histological evaluation is thus crucial for the definition of patients' prognosis. However, within each histological subtype, tumor behavior can be highly variable, and, in this respect, molecular characterization can provide insightful information to refine the risk stratification of tumors. In addition to the importance of its prognostic role, molecular testing can be used to support the differential diagnosis of thyroid nodules in the absence of marked cyto-morphological aberrations. Finally, with the advent of targeted drugs, the presence of molecular alterations will guide the therapeutic strategies for patients with advanced tumors who do not respond to standard treatment. This review aims to describe the genetic landscape of follicular-derived thyroid tumors also highlighting differences across histological subtypes.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [1] Management of localized follicular-derived thyroid cancer
    Lamartina, Livia
    Grunenwald, Solange
    Roy, Malanie
    HartI, Dana
    Buffet, Camille
    BULLETIN DU CANCER, 2024, 111 (10) : 10S19 - 10S30
  • [2] Indications for radioiodine administration in follicular-derived thyroid cancer
    Buffet, C.
    Ghander, C.
    le Marois, E.
    Leenhardt, L.
    ANNALES D ENDOCRINOLOGIE, 2015, 76 : 1S2 - 1S7
  • [3] Nutritional status and follicular-derived thyroid cancer: An update
    Barrea, Luigi
    Gallo, Marco
    Ruggeri, Rosaria Maddalena
    Di Giacinto, Paola
    Sesti, Franz
    Prinzi, Natalie
    Adinolfi, Valerio
    Barucca, Viola
    Renzelli, Valerio
    Muscogiuri, Giovanna
    Colao, Annamaria
    Baldelli, Roberto
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2021, 61 (01) : 25 - 59
  • [4] The sonographic appearance of follicular-derived thyroid malignancies
    Langer, JE
    Nisenbaum, HL
    Horii, SC
    Coleman, BG
    Mandel, SJ
    RADIOLOGY, 2000, 217 : 515 - 515
  • [5] Uncommon molecular alterations in follicular-derived thyroid carcinoma: A single institution study
    Alexiev, Borislav A.
    Vormittag-Nocito, Erica R.
    Lorch, Jochen
    Yeldandi, Anjana
    Buttars, Paul R.
    Jennings, Lawrence J.
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 258
  • [6] Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy
    Turner, Naimah
    Hamidi, Sarah
    Ouni, Rim
    Rico, Rene
    Henderson, Ying C.
    Puche, Maria
    Alekseev, Sayan
    Colunga-Minutti, Jocelynn G.
    Zafereo, Mark E.
    Lai, Stephen Y.
    Kim, Sang T.
    Cabanillas, Maria E.
    Nurieva, Roza
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [7] Cytologic features of aggressive variants of follicular-derived thyroid carcinoma
    Rossi, Esther Diana
    Faquin, William C.
    Pantanowitz, Liron
    CANCER CYTOPATHOLOGY, 2019, 127 (07) : 432 - 446
  • [8] Intracapsular (Eggshell) Calcification as a Harbinger of Malignancy in Follicular-Derived Thyroid Tumors
    Chu, Ying-Hsia
    Nose', Vania
    Sadow, Peter
    Wang, Yanping
    Yu, Qiqi
    Hu, Rong
    Lloyd, Ricardo
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 572 - 572
  • [9] Everolimus in Patients With Advanced Follicular-Derived Thyroid Cancer: Results of a Phase II Clinical Trial
    Schneider, Tatiana C.
    de Wit, Djoeke
    Links, Thera P.
    van Erp, Nielka P.
    van der Hoeven, Jakobus J. M.
    Gelderblom, Hans
    Roozen, Inge C. F. M.
    Bos, Manon
    Corver, Wim E.
    van Wezel, Tom
    Smit, Jan W. A.
    Morreau, Hans
    Guchelaar, Henk-Jan
    Kapiteijn, Ellen
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (02): : 698 - 707
  • [10] Intracapsular (Eggshell) Calcification as a Harbinger of Malignancy in Follicular-Derived Thyroid Tumors
    Chu, Ying-Hsia
    Nose', Vania
    Sadow, Peter
    Wang, Yanping
    Yu, Qiqi
    Hu, Rong
    Lloyd, Ricardo
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 572 - 572